Glucagon-like peptide-1 inhibits LPS-induced IL-1β production in cultured rat astrocytes
Glucagon-like peptide-1 inhibits LPS-induced IL-1β production in cultured rat astrocytes
复制标题
DOI:
10.1016/j.neures.2006.04.008
复制
发表时间:
2006-08-01
影响因子:
2.9
通讯作者:
Oka, Jun-Ichiro
中科院分区:
文献类型:
--
作者:
Iwai, Takashi;Ito, Satoshi;Oka, Jun-Ichiro
Glia play an important role in neurotoxicity in neurodegenerative diseases. In this study, we investigated the expression of glucagon-like peptide-1 (GLP-1) and its receptor, and the effects of GLP-1 on lipopolysaccharide (LPS)-induced IL-1 beta mRNA expression and IL-1 beta production in glia. GLP-1-like immunoreactivity was observed in amoeboid microglia, but not ramified microglia or astrocytes. GLP-1 binding and GLP-1 receptor mRNA expression were observed in both astrocytes and microglia. GLP-1-induced morphological changes in microglia from the ramified type to the amoeboid type, suggesting an increase in production and release of endogenous GLP-1. GLP-1 prevented the LPS-induced IL-I beta mRNA expression, which effect was, in turn, inhibited by pretreatment with SQ22536, an adenylate cyclase inhibitor. GLP-1 also increased cAMP concentration and cAMP response element-binding protein phosphorylation in astrocytes. These results suggest that GLP-1 may be a modulator of inflammation in the central nervous system. (c) 2006 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.